The 2018 global “Erectile Dysfunction Drugs Market” report delivers key information on the marketplace of the Erectile Dysfunction Drugs, which could be a great source of guidance and direction for drug manufacturers and people interested in the industry.
There is a section in the report for competition landscape of the global Erectile Dysfunction Drugs Industry.
The report contains the information of Global Erectile Dysfunction Drugs, such as Viagra, Cialis, Levitra, Stendra, Zydena, etc. and the end users, such as clinics, pharmaceutical companies, hospitals, etc. The report also contains the information of forecast to 2023.
The drug manufacturers and an increasing number of men suffering from this sexual disorder drive the Erectile Dysfunction Drugs Market. Also, there has been stiff competition between the major pharma companies.
Patent expiry of blockbuster drugs and the availability of generic drugs may result in the decline of Erectile Dysfunction Drugs Market. The market is estimated to reach around $2.95 billion in 2023 from $1.65 billion in 2016 with a Compound Annual Growth Rate (CAGR) of nearly 6.5% from 2017 to 2023.
The main objective of this study is to provide relevant information about Erectile Dysfunction Drugs Market, medications and end users. It has been conducted to provide detailed analysis, key insights, forecast revenue, competitive developments, strategic alliances, etc.
- Basic details related to Erectile Dysfunction Drugs industry such as product information, product segmentation, product price, and product demand and supply.
- The comprehensive study based on the development strategies and opportunities, growth-limiting factors, and the practicability of investment, keeping forecast of the market growth.
- The study of emerging and existing market segments to help the readers in planning and implementing business strategies.
The study report includes the regions such as North America, Europe, Asia-Pacific, South America, Middle East, and Africa.
The report focuses on the top pharma companies, such as Apricus Biosciences Inc., Cristalia Produtos Quimicos Farmaceuticos Ltd, Pfizer, Bayer AG, Dong-A ST Co.Ltd, Eli Lilly and Company, Meda Pharmaceuticals Inc., SK Chemicals, Teva Pharmaceutical Industries Ltd, and VIVUS, Inc. etc.
The Erectile Dysfunction Drugs Market report mainly emphases on ED Drugs Industry in the global market. The report provides regional information and country-level evaluation for existing as well as new players of the market to extend their own belief. The report also provides an evaluation of the price, demand, supply chain, as well as growth and constraining factors.
In India, in May 2017, Lupin Limited launched Cialis, a Tadalafil-containing ED drug through a licensing agreement with Eli Lilly that will be responsible for developing and importing the medicine.
In December 2017, Pfizer, the manufacturer of Viagra (Sildenafil Citrate), settled some trade disputes with the generic manufacturer, Teva Pharmaceutical Industries Limited. This settlement allows Teva to sell Generic Viagra (Sildenafil Citrate), which may boost the usage rates.
The report also investigates the regional analysis and evaluation of the Erectile Dysfunction Drugs Industry growth rate, sales, revenue, and cost as per the regions. The 2018 Global Erectile Dysfunction Drugs market report presents the information, which has been derived from reliable and authentic sources that are endorsed by experts of this particular industry.
Lastly, the 2018 Global Erectile Dysfunction Drugs Market report describes Erectile Dysfunction Drugs Industry expansion and game plan, the knowledge supply, overview, analysis, and the conclusion.
About Erectile Dysfunction The inability to attain and sustain an erection firm enough during sexual intercourse is called Erectile Dysfunction. Also known as impotence, Erectile Dysfunction is a common sexual disorder primarily affecting men above 40 years of age. Certain physical and psychological factors are responsible for causing ED in men. Drugs such as Viagra, Cialis, Levitra, and Stendra help men to overcome erectile dysfunction by boosting blood flow to the penile organ.